Open access
Open access
Powered by Google Translator Translator

Randomized Trial: Effect of Low-Dose Vasopressin on Need for Transfusions in Patients With Trauma and Hemorrhagic Shock

29 Aug, 2019 | 06:45h | UTC

Effect of Low-Dose Supplementation of Arginine Vasopressin on Need for Blood Product Transfusions in Patients With Trauma and Hemorrhagic Shock: A Randomized Clinical Trial – JAMA Surgery (free for a limited period)

Commentaries: Vasopressin as an Early Adjunct to Resuscitation in Hemorrhagic Shock: Crisis AVERTed? – JAMA Surgery (free) AND Giving trauma patients blood pressure stabilizing hormone cuts transfusions by half – University of Pennsylvania School of Medicine (free)

Author Interview: Arginine Vasopressin Supplementation in Early Traumatic Shock (free)

“Additional research is necessary to determine whether including AVP improves morbidity or mortality.”

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.